Ensysce Biosciences
ENSC
ENSC
21 hedge funds and large institutions have $6.23M invested in Ensysce Biosciences in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
Holders
21
Holders Change
+3
Holders Change %
+16.67%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
5
Closed
4
Calls
$225K
Puts
–
Net Calls
+$225K
Net Calls Change
+$225K
Top Buyers
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$0 |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$140K |
| 3 |
3
Jane Street
New York
|
$0 |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$12K |
| 5 |
5
JPMorgan Chase & Co
New York
|
$0 |
